Phase I/II trial of nimotuzumab in combination with radiotherapy in patients with stage IIb-III non-small cell lung cancer.
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 03 Jun 2008
At a glance
- Drugs Nimotuzumab (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 03 Jun 2008 Updated preliminary results presented at ASCO 2008.
- 08 May 2008 Status change from recruiting to in progress, according to YM Biosciences.
- 10 Apr 2006 New trial record.